InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Smith Mark Alan, Directeur Médical. Insider active across 1 companies, notably VistaGen Therapeutics, Inc.. Aggregated, 4 disclosures have been logged. The latest transaction was filed on 31 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
€3,8862,655 shares@ €1.46360.016% mcap25.6% of flow
Common Stock
SEC:0001415889-22-000046:0·
€3,8862,655 shares@ €1.46360.016% mcap51.2% of flow
Common Stock
SEC:0001415889-22-000046·
€3,7102,260 shares@ €1.64170.015% mcap48.8% of flow
Common Stock
SEC:0001415889-21-003388·
€3,7102,260 shares@ €1.64170.015% mcap24.4% of flow
Common Stock
SEC:0001415889-21-003388:0·
4 of 4 declarations
About Smith Mark Alan
Smith Mark Alan serves as the Chief Medical Officer at VistaGen Therapeutics, Inc. He oversees the company's clinical and research initiatives, ensuring that drug development programs meet safety and efficacy standards. His role is crucial for innovation in the healthcare sector.
